Eric T. Lubiner

Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score

Martine Extermann, I. Boler, Richard R. Reich et al. · Cancer · 2011 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Oncology +17

The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: Design and validation.

Martine Extermann, I. Boler, Richard R. Reich et al. · Journal of Clinical Oncology · 2010 · 51 citations

Nursing, Oncology, Geriatric Oncology Pharmacotherapy +1

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer

David R. Spigel, F. Anthony Greco, Mark S. Rubin et al. · Lung Cancer · 2012 · 40 citations

Medicine, Oncology, Pharmacology +14

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

David R. Spigel, John D. Hainsworth, Dianna Shipley et al. · Journal of Thoracic Oncology · 2011 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +9